Entia Biosciences, Inc. (ERGO)

Market Cap	3.41K
Revenue (ttm)	265.47K
Net Income (ttm)	-1.40M
Shares Out	34.06M
EPS (ttm)	-0.05
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	78,461
Average Volume	22,296
Open	0.0001
Previous Close	0.0001
Day's Range	0.0001 - 0.0001
52-Week Range	0.0000 - 0.0002
Beta	21.02
RSI	40.96
Earnings Date	n/a

About Entia Biosciences

Entia Biosciences, Inc. engages in the development, production, and distribution of dietary supplements, nutraceuticals, and medical foods products in the United States. It is also involved in the discovery, scientific evaluation, and marketing of natural formulations that can be used in medical foods, nutraceuticals, cosmetics, and other products. The company’s portfolio of formulations include ErgoD2, a pharmaceutical grade organic compound from whole food that contains the micro-nutrients; L-Ergothioneine, a naturally occurring amino acid an...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2007
• Employees: 7
• Stock Exchange: OTCMKTS
• Ticker Symbol: ERGO

Financial Performance

In 2016, Entia Biosciences's revenue was $265,466, a decrease of -23.48% compared to the previous year's $346,910. Losses were -$1.40 million, -38.24% less than in 2015.